Author: Xie, Yun; Cao, Song; Dong, Hui; Lv, Hui; Teng, Xiaolei; Zhang, Jiaxiang; Wang, Tao; Zhang, Xiaoyan; Qin, Yun; Chai, Yujing; Yang, Luyu; Liu, Jun; Wang, Ruilan
Title: Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation Cord-id: at99z1cp Document date: 2021_9_15
ID: at99z1cp
Snippet: BACKGROUND: Our goal is to further elucidate the clinical condition and prognosis of patients with severe acute COVID-19 with EBV reactivation. METHOD: This is a retrospective single-center study of COVID-19 patients admitted to the intensive care unit of Wuhan No. 3 Hospital (January 31 to March 27, 2020). According to whether Epstein-Barr virus reactivation was detected, the patients were divided into an EBV group and a Non-EBV group. Baseline data were collected including epidemiological, lar
Document: BACKGROUND: Our goal is to further elucidate the clinical condition and prognosis of patients with severe acute COVID-19 with EBV reactivation. METHOD: This is a retrospective single-center study of COVID-19 patients admitted to the intensive care unit of Wuhan No. 3 Hospital (January 31 to March 27, 2020). According to whether Epstein-Barr virus reactivation was detected, the patients were divided into an EBV group and a Non-EBV group. Baseline data were collected including epidemiological, larithmics, clinical and imaging characteristics, and laboratory examination data. RESULTS: Of the 128 patients with COVID-19, 17 (13.3%) were infected with Epstein-Barr virus reactivation. In the symptoms,the rate of tachypnoea in the EBV group was apparently higher than that in the Non-EBV group. In lab tests, the lymphocyte and albumin of EBV group decreased more significantly than Non-EBV group, and the D-dimer and serum calcium of EBV group was higher than Non-EBV group. Regarding the infection index, CRP of EBV group was apparently above the Non-EBV group, and no significant difference was found in procalcitonin of the two groups. The incidence of respiratory failure, ARDS, and hypoproteinaemia of EBV group had more incidence than Non-EBV group. The 28-day and 14-day mortality rates of EBV group was significantly higher than that of Non-EBV group. CONCLUSIONS: In the COVID-19 patients, patients with EBV reactivation had higher 28-day and 14-day mortality rates and received more immuno-supportive treatment than patients of Non-EBV group.
Search related documents:
Co phrase search for related documents- acute kidney injury and low albumin: 1, 2, 3, 4, 5, 6, 7, 8
- acute kidney injury and low lymphocyte: 1, 2
- acute kidney injury and low platelet count: 1, 2, 3, 4
- acute kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- acute liver and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62
- acute liver and low albumin: 1
- acute liver and low lymphocyte: 1, 2, 3
- acute liver and low platelet count: 1, 2, 3
- acute liver and lymphocyte count: 1, 2, 3, 4, 5, 6
- acute liver injury and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute liver injury and low lymphocyte: 1, 2
- acute liver injury and lymphocyte count: 1, 2, 3
- acute myocardial and liver function: 1, 2
- acute myocardial and low lymphocyte: 1
- acute myocardial and low platelet count: 1
- acute myocardial and lymphocyte count: 1, 2, 3, 4, 5
- acute myocardial injury and liver function: 1
- acute myocardial injury and lymphocyte count: 1, 2
- acute respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
Co phrase search for related documents, hyperlinks ordered by date